Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Recruiting 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1

Conditions

Rectal Neoplasms 1Inflammation 1Carcinoma, Renal Cell 1Acute Kidney Injury 1

Interventions

pembrolizumab 1273Specimen Handling 871Carboplatin 832Magnetic Resonance Spectroscopy 808Cyclophosphamide 803Cisplatin 729Nivolumab 659Paclitaxel 631Radiotherapy 574Gemcitabine 572Biopsy 529Bevacizumab 476Dexamethasone 440fludarabine 407Docetaxel 378venetoclax 370Oxaliplatin 365Capecitabine 358Fluorouracil 355atezolizumab 344durvalumab 334Rituximab 333Doxorubicin 317Radiosurgery 309Pemetrexed 306Drug Therapy 303Ipilimumab 294Standard of Care 293Etoposide 285Radiation 281

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Ischemic Preconditioning × 1 year × Clear all
NCT07497958 2026-03-27

Ischemic Preconditioning Reduces the Severity of Acute Kidney Injury After Partial Nephrectomy

Sun Yat-sen University

Phase NA Not yet recruiting
174 enrolled
Genitourinary

Carcinoma, Renal Cell, Acute Kidney Injury

NCT06236633 2025-12-04

AMIREMBOL_2

Centre Hospitalier Universitaire de Nīmes

Phase NA Recruiting
30 enrolled
Gastrointestinal

Rectal Neoplasms

NCT07117643 2025-08-12

Ischemic Preconditioning - Perspectives of Use Vivio/in Vitro Studies

Gdansk University of Physical Education and Sport

Phase NA Enrolling by invitation
250 enrolled

Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡